🇺🇸 FDA
Patent

US 6737059

Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis

expired A61KA61K2039/505A61K38/00

Quick answer

US patent 6737059 (Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis) held by The Board of Regents of the University of Washington expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Washington
Grant date
Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P29/00